Terms: = Lymphoma AND SERPINE1, PAI, PAI-1, PAI1, PLANH1 AND Treatment
21 results:
1. Relative hypercoagulation induced by suppressed fibrinolysis after tisagenlecleucel infusion in malignant lymphoma.
Yamasaki-Morita M; Arai Y; Ishihara T; Onishi T; Shimo H; Nakanishi K; Nishiyama Y; Jo T; Hiramatsu H; Mitsuyoshi T; Mizumoto C; Kanda J; Nishikori M; Kitawaki T; Nogami K; Takaori-Kondo A; Nagao M; Adachi S
Blood Adv; 2022 Jul; 6(14):4216-4223. PubMed ID: 35580321
[TBL] [Abstract] [Full Text] [Related]
2. Biomarkers of Glucose Metabolism Alterations and the Onset of Metabolic Syndrome in Survivors of Childhood Acute Lymphoblastic Leukemia.
Konończuk K; Muszyńska-Rosłan K; Konstantynowicz-Nowicka K; Krawczuk-Rybak M; Chabowski A; Latoch E
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409072
[TBL] [Abstract] [Full Text] [Related]
3. Accelerated atherosclerosis, hyperlipoproteinemia and insulin resistance in long-term survivors of Hodgkin lymphoma during childhood and adolescence.
Cepelova M; Kruseova J; Luks A; Capek V; Cepela P; Potockova J; Kraml P
Neoplasma; 2019 Nov; 66(6):978-987. PubMed ID: 31305124
[TBL] [Abstract] [Full Text] [Related]
4. Endothelial Function in Children with Acute Lymphoblastic Leukemia (ALL) May Reflect the Clinical Outcome.
Doroszko A; Niedzielska E; Jakubowski M; Porwolik J; Turek-Jakubowska A; Szahidewicz-Krupska E; Sieczkowski B; Dobrowolski P; Radziwon A; Skomro R; Derkacz A; Mazur G; Chybicka A; Szuba A
Biomed Res Int; 2018; 2018():7918091. PubMed ID: 30534565
[TBL] [Abstract] [Full Text] [Related]
5. Primary adrenal insufficiency due to bilateral infiltrative disease.
Herndon J; Nadeau AM; Davidge-Pitts CJ; Young WF; Bancos I
Endocrine; 2018 Dec; 62(3):721-728. PubMed ID: 30178435
[TBL] [Abstract] [Full Text] [Related]
6. Venoocclusive disease due to chemotherapy for pediatric acute lymphoblastic leukemia is associated with increased levels of plasminogen-activator inhibitor-1.
Mauro M; Saggiorato G; Sartori MT; Gallo G; De Bortoli M; Bonetti E; Zaccaron A; Vitale V; Balter R; Chinello M; Cesaro S
Pediatr Blood Cancer; 2018 Jun; 65(6):e26963. PubMed ID: 29350496
[TBL] [Abstract] [Full Text] [Related]
7. Protein Z (PZ) and plasminogen activator inhibitor-1 (pai-1) plasma levels in patients with previously untreated Hodgkin lymphoma (HL).
Boutsikas G; Terpos E; Markopoulos A; Papatheodorou A; Stefanou A; Georgiou G; Galani Z; Komninaka V; Telonis V; Anagnostopoulos I; Dimitrakopoulou L; Anargyrou K; Tsionos K; Christoulas D; Gonianaki M; Giannikos T; Kokoris S; Konstantopoulos K; Meletis J; Angelopoulou MK; Travlou A; Vassilakopoulos TP
J BUON; 2017; 22(4):1022-1031. PubMed ID: 28952223
[TBL] [Abstract] [Full Text] [Related]
8. Coagulation profile during induction chemotherapy in childhood acute lymphoblastic leukemia.
Sehgal S; Sharma S; Chandra J; Nangia A
Indian J Pathol Microbiol; 2017; 60(1):50-56. PubMed ID: 28195091
[TBL] [Abstract] [Full Text] [Related]
9. Gene expression analysis in radiotherapy patients and C57BL/6 mice as a measure of exposure to ionizing radiation.
Filiano AN; Fathallah-Shaykh HM; Fiveash J; Gage J; Cantor A; Kharbanda S; Johnson MR
Radiat Res; 2011 Jul; 176(1):49-61. PubMed ID: 21361780
[TBL] [Abstract] [Full Text] [Related]
10. Physical activity and fitness in adolescent and young adult long-term survivors of childhood acute lymphoblastic leukaemia.
Järvelä LS; Niinikoski H; Lähteenmäki PM; Heinonen OJ; Kapanen J; Arola M; Kemppainen J
J Cancer Surviv; 2010 Dec; 4(4):339-45. PubMed ID: 20552291
[TBL] [Abstract] [Full Text] [Related]
11. Downregulation of ZEB1 and overexpression of Smad7 contribute to resistance to TGF-beta1-mediated growth suppression in adult T-cell leukemia/lymphoma.
Nakahata S; Yamazaki S; Nakauchi H; Morishita K
Oncogene; 2010 Jul; 29(29):4157-69. PubMed ID: 20514018
[TBL] [Abstract] [Full Text] [Related]
12. Evaluation of Helicobacter pylori vacA genotypes in Iranian patients with peptic ulcer disease.
Salehi Z; Abadi AS; Ismail PB; Kqueen CY; Jelodar MH; Kamalidehghan B
Dig Dis Sci; 2009 Nov; 54(11):2399-403. PubMed ID: 19082887
[TBL] [Abstract] [Full Text] [Related]
13. 1p31, 7q21 and 18q21 chromosomal aberrations and candidate genes in acquired vinblastine resistance of human cervical carcinoma KB cells.
Wang J; Tai LS; Tzang CH; Fong WF; Guan XY; Yang M
Oncol Rep; 2008 May; 19(5):1155-64. PubMed ID: 18425371
[TBL] [Abstract] [Full Text] [Related]
14. A pai-1 (serpine1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.
French D; Hamilton LH; Mattano LA; Sather HN; Devidas M; Nachman JB; Relling MV;
Blood; 2008 May; 111(9):4496-9. PubMed ID: 18285546
[TBL] [Abstract] [Full Text] [Related]
15. The novel anti-tumour agent oxamflatin differentially regulates urokinase and plasminogen activator inhibitor type 2 expression and inhibits urokinase-mediated proteolytic activity.
Dear AE; Medcalf RL
Biochim Biophys Acta; 2000 Jun; 1492(1):15-22. PubMed ID: 11004477
[TBL] [Abstract] [Full Text] [Related]
16. Urokinase-mediated transactivation of the plasminogen activator inhibitor type 2 (pai-2) gene promoter in HT-1080 cells utilises AP-1 binding sites and potentiates phorbol ester-mediated induction of endogenous pai-2 mRNA.
Dear AE; Costa M; Medcalf RL
FEBS Lett; 1997 Feb; 402(2-3):265-72. PubMed ID: 9037208
[TBL] [Abstract] [Full Text] [Related]
17. [The significance of plasminogen activator inhibitor 2 in patients with hematologic malignancies].
Cetkovský P; Koza V; Cepelák V; Vít L
Vnitr Lek; 1993 Sep; 39(9):871-5. PubMed ID: 8212641
[TBL] [Abstract] [Full Text] [Related]
18. Detection of both type 1 and type 2 plasminogen activator inhibitors in human cells.
Schleef RR; Wagner NV; Loskutoff DJ
J Cell Physiol; 1988 Feb; 134(2):269-74. PubMed ID: 3257967
[TBL] [Abstract] [Full Text] [Related]
19. Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells.
Genton C; Kruithof EK; Schleuning WD
J Cell Biol; 1987 Mar; 104(3):705-12. PubMed ID: 3102504
[TBL] [Abstract] [Full Text] [Related]
20. Plasminogen activator-specific inhibitors produced by human monocytes/macrophages.
Wohlwend A; Belin D; Vassalli JD
J Exp Med; 1987 Feb; 165(2):320-39. PubMed ID: 2434595
[TBL] [Abstract] [Full Text] [Related]
[Next]
